Literature DB >> 9836530

Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content: vascular endothelial growth factor decreases occludin in retinal endothelial cells. Penn State Retina Research Group.

D A Antonetti1, A J Barber, S Khin, E Lieth, J M Tarbell, T W Gardner.   

Abstract

Blood-retinal barrier (BRB) breakdown is a hallmark of diabetic retinopathy, but the molecular changes that cause this pathology are unclear. Occludin is a transmembrane component of interendothelial tight junctions that may regulate permeability at the BRB. In this study, we examined the effects of vascular endothelial growth factor (VEGF) and diabetes on vascular occludin content and barrier function. Sprague-Dawley rats were made diabetic by intravenous streptozotocin injection, and age-matched animals served as controls. After 3 months, BRB permeability was quantified by intravenous injection of fluorescein isothiocyanate-bovine serum albumin (FITC-BSA), Mr 66 kDa, and 10-kDa rhodamine-dextran (R-D), followed by digital image analysis of retinal sections. Retinal fluorescence intensity for FITC-BSA increased 62% (P < or = 0.05), but R-D fluorescence did not change significantly. Occludin localization at interendothelial junctions was confirmed by immunofluorescence, and relative protein content was determined by immunoblotting of retinal homogenates. Retinal occludin content decreased approximately 35% (P < or = 0.03) in the diabetic versus the control animals, whereas the glucose transporter GLUT1 content was unchanged in rat retinas. Additionally, treatment of bovine retinal endothelial cells in culture with 0.12 nmol/l or 12 nmol/l VEGF for 6 h reduced occludin content 46 and 54%, respectively. These data show that diabetes selectively reduces retinal occludin protein expression and increases BRB permeability. Our findings suggest that the elevated VEGF in the vitreous of patients with diabetic retinopathy increases vascular permeability by downregulating occludin content. Decreased tight junction protein expression may be an important means by which diabetes causes increased vascular permeability and contributes to macular edema.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9836530     DOI: 10.2337/diabetes.47.12.1953

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  175 in total

Review 1.  The absence of diabetic retinopathy in patients with retinitis pigmentosa: implications for pathophysiology and possible treatment.

Authors:  G B Arden
Journal:  Br J Ophthalmol       Date:  2001-03       Impact factor: 4.638

Review 2.  The molecular structure and function of the inner blood-retinal barrier. Penn State Retina Research Group.

Authors:  T W Gardner; D A Antonetti; A J Barber; E Lieth; J A Tarbell
Journal:  Doc Ophthalmol       Date:  1999       Impact factor: 2.379

3.  miR-15a/16 inhibits TGF-beta3/VEGF signaling and increases retinal endothelial cell barrier proteins.

Authors:  Eun-Ah Ye; Li Liu; Jena J Steinle
Journal:  Vision Res       Date:  2017-08-07       Impact factor: 1.886

Review 4.  [Surgery for macular edema].

Authors:  C Haritoglou; A Kampik
Journal:  Ophthalmologe       Date:  2004-06       Impact factor: 1.059

5.  Novel atypical PKC inhibitors prevent vascular endothelial growth factor-induced blood-retinal barrier dysfunction.

Authors:  Paul M Titchenell; Cheng-Mao Lin; Jason M Keil; Jeffrey M Sundstrom; Charles D Smith; David A Antonetti
Journal:  Biochem J       Date:  2012-09-15       Impact factor: 3.857

6.  Extract of Litsea japonica ameliorates blood-retinal barrier breakdown in db/db mice.

Authors:  Junghyun Kim; Chan-Sik Kim; Ik Soo Lee; Yun Mi Lee; Eunjin Sohn; Kyuhyung Jo; Joo Hwan Kim; Jin Sook Kim
Journal:  Endocrine       Date:  2013-11-28       Impact factor: 3.633

7.  Enhanced permeability responses to inflammation in streptozotocin-induced diabetic rat venules: Rho-mediated alterations of actin cytoskeleton and VE-cadherin.

Authors:  Dong Yuan; Sulei Xu; Pingnian He
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-04-28       Impact factor: 4.733

Review 8.  A proposal for early and personalized treatment of diabetic retinopathy based on clinical pathophysiology and molecular phenotyping.

Authors:  Thomas W Gardner; Jeffrey M Sundstrom
Journal:  Vision Res       Date:  2017-08-02       Impact factor: 1.886

9.  CD8 T cell-initiated vascular endothelial growth factor expression promotes central nervous system vascular permeability under neuroinflammatory conditions.

Authors:  Georgette L Suidan; Jonathan W Dickerson; Yi Chen; Jeremiah R McDole; Pulak Tripathi; Istvan Pirko; Kim B Seroogy; Aaron J Johnson
Journal:  J Immunol       Date:  2009-12-11       Impact factor: 5.422

10.  [Cytokine determination from vitreous samples in retinal vascular diseases].

Authors:  M Pfister; F H Koch; J Cinatl; F Rothweiler; R Schubert; P Singh; H Ackermann; M J Koss
Journal:  Ophthalmologe       Date:  2013-08       Impact factor: 1.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.